{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T23:40:24Z","timestamp":1655595624363},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nrl.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T04:55:54Z","timestamp":1461819354000},"page":"201-202","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linfomatosis men\u00edngea tard\u00eda en linfoma del manto controlada con quimioterapia"],"prefix":"10.1016","volume":"33","author":[{"given":"J.J.","family":"Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Ri\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2016.02.014_bib0055","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.23615","article-title":"Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management","volume":"88","author":"Vose","year":"2013","journal-title":"Am J Hematol."},{"key":"10.1016\/j.nrl.2016.02.014_bib0060","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdt139","article-title":"Central nervous system involvement in mantle cell lymphoma: Clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network","volume":"24","author":"Cheah","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.nrl.2016.02.014_bib0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdm447","article-title":"Central nervous system involvement in mantle cell lymphoma","volume":"19","author":"Ferrer","year":"2008","journal-title":"Ann Oncol."},{"key":"10.1016\/j.nrl.2016.02.014_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.2009.07835.x","article-title":"Mantle cell lymphoma with central nervous system involvement: frequency and clinical features","volume":"147","author":"Gill","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nrl.2016.02.014_bib0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.nrl.2016.02.014_bib0080","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3109\/10428194.2013.767454","article-title":"Risk factors of central nervous system relapse in mantle cell lymphoma","volume":"54","author":"Conconi","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.nrl.2016.02.014_bib0085","first-page":"28","article-title":"Recent trends in the management of lymphomas at M.D. Anderson Cancer Center","volume":"17","author":"Cabanillas","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/j.nrl.2016.02.014_bib0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/10428190109097668","article-title":"Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting","volume":"40","author":"Ladetto","year":"2001","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.nrl.2016.02.014_bib0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/CAD.0b013e32830cebc1","article-title":"Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma","volume":"19","author":"Villela","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.nrl.2016.02.014_bib0100","doi-asserted-by":"crossref","unstructured":"Bernard S, Goldwirt L, Amorim S, Brice P, Bri\u00e8re J, de Kerviler E, et al. Activity with ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood. 2015. pii: blood-2015-05-64783.","DOI":"10.1182\/blood-2015-05-647834"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316300019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316300019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T23:06:53Z","timestamp":1655593613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485316300019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0213485316300019"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2016.02.014","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linfomatosis men\u00edngea tard\u00eda en linfoma del manto controlada con quimioterapia","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}